Holly May
Corporate Officer/Principal bei BIOLINERX LTD.
Vermögen: - $ am 31.03.2024
Ursprung des Netzwerks ersten Grades von Holly May
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 16 | |
| Public Company | Pharmaceuticals: Major | 15 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Holly May
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Pharmaceuticals: Generic | Corporate Officer/Principal Director/Board Member Chief Operating Officer | |
Forticell Bioscience, Inc.
 Forticell Bioscience, Inc. BiotechnologyHealth Technology Forticell Bioscience, Inc. focuses on advanced regenerative medicine and stem cell therapy. The company was founded in 1991 and is headquartered in Englewood Cliffs, NJ. | Biotechnology | Director/Board Member | |
| COMPUGEN LTD. | Biotechnology | Corporate Officer/Principal | |
Nanomedical Systems, Inc.
 Nanomedical Systems, Inc. Medical SpecialtiesHealth Technology Nanomedical Systems, Inc. is an innovation company focused on the commercialization of revolutionary silicon-based medical nanotechnology products that address unmet clinical needs for personalized medicine. Its technology platforms embody semiconductor, biotechnology, nano-materials, and medical sciences. The company was founded by Mauro Ferrari, Randal K. Goodall, David D. Saathoff in 2007 and is headquartered in Dave Saathoff, TX. | Medical Specialties | Director/Board Member | |
| BETTERLIFE PHARMA INC. | Pharmaceuticals: Major | Chief Executive Officer | |
| The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin Masters Business Admin | |
| KARO PHARMA AB (PUBL) | Pharmaceuticals: Major | Director of Finance/CFO | |
| MEDA AB | Pharmaceuticals: Major | Director of Finance/CFO Investor Relations Contact | |
| BIOTAGE AB | Medical Specialties | Director of Finance/CFO | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member | |
| University of Uppsala | College/University | Undergraduate Degree | |
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel. | College/University | Corporate Officer/Principal Graduate Degree Doctorate Degree | |
| The Hebrew University of Jerusalem | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree Masters Business Admin Undergraduate Degree Graduate Degree Doctorate Degree | |
| CALLIDITAS THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
University of Connecticut Health Center
 University of Connecticut Health Center Other Consumer ServicesConsumer Services University of Connecticut Health Center provides healthcare services. It is an organization, which composed of the school of medicine, John Dempsey hospital, the UConn medical group & health partners, and university dentists. It offers services for cardiovascular, cancer, behavioral, ambulatory, and neonatal intensive-care. The company was founded in 1961 and is headquartered in Farmington, CT. | College/University | Doctorate Degree | |
The Jackson Laboratory
 The Jackson Laboratory BiotechnologyHealth Technology The Jackson Laboratory provides biotechnology research services. It offers nonprofit research, biomedical research, genomics, genetics, cancer, neuroscience, immunology, aging, bioinformatics, computational biology, research mice, genomic medicine, reproductive biology, developmental biology, eye research and hearing research. The company was founded by Clarence Cook Little in 1929 and is headquartered in Bar Harbor, ME. | Biotechnology | Corporate Officer/Principal | |
| University of Oslo | College/University | Doctorate Degree | |
| Weizmann Institute of Science | College/University | Doctorate Degree Graduate Degree | |
Hadasit Medical Research Services & Development Ltd.
 Hadasit Medical Research Services & Development Ltd. Miscellaneous Commercial ServicesCommercial Services Hadasit Medical Research Services & Development Ltd. operates as technology transfer company of Hadassah Medical Center in Jerusalem. It identifies, protects, nurtures and commercializes the discoveries made at Hadassah Medical Center. The company's product include Doxil, Periochip, Travelan, Granagard, and Insupad. The company was founded on December 7, 1986 and is headquartered in Jerusalem, Israel. | Miscellaneous Commercial Services | Chief Executive Officer | |
LifeBond Ltd.
 LifeBond Ltd. Medical SpecialtiesHealth Technology LifeBond Ltd. engages in the development of medical devices designed to restore and repair tissues to reduce post-operative complications. The company was founded by Nir Mashkif, Orahn Preiss-Bloom and Ishay Attar in 2007 and is headquartered in Caesarea, Israel. | Medical Specialties | Chairman | |
| EVOGENE LTD. | Biotechnology | Director/Board Member Director/Board Member | |
OxThera AB
 OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Generic | Director of Finance/CFO Director/Board Member | |
Cell Cure Neurosciences Ltd.
 Cell Cure Neurosciences Ltd. BiotechnologyHealth Technology Cell Cure Neurosciences Ltd. develops cell therapies for neural degenerative diseases. Its therapeutic cells include retinal pigmented epithelial (RPE) cells and neural progenitor cells. The firm's cells are derived from human embryonic stem cells (hESCs), which are considered to be the gold standard source of cells for the development of stem cell therapies. The company was founded in 2005 and is headquartered in Jerusalem, Israel. | Biotechnology | Director/Board Member | |
Pfizer Health AB
 Pfizer Health AB Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Pfizer Health AB is a pharmaceutical company that manufactures pharmaceutical products. The private company is based in Straengnaes, Sweden. The Swedish company was founded in 1969. The CEO is Helena Viktoria Thelin. | Pharmaceuticals: Major | Chief Executive Officer | |
| The College of Management Academic Studies | College/University | Undergraduate Degree Graduate Degree | |
Brightman Almagor Zohar & Co.
 Brightman Almagor Zohar & Co. Miscellaneous Commercial ServicesCommercial Services Brightman Almagor Zohar & Co. provides auditing and accounting services to technology, media, telecommunication, real estate, and financial services sectors. The company offers budget control and cost accounting; business planning; transfer pricing; real estate taxation; and audit committee services. The company is headquartered in Tel Aviv, Israel. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor Director/Board Member | |
| Medical University Sofia | College/University | Doctorate Degree | |
| Life Sciences Ontario | Director/Board Member | ||
Centre For Commercialization of Regenerative Medicine
 Centre For Commercialization of Regenerative Medicine BiotechnologyHealth Technology Centre For Commercialization of Regenerative Medicine supports our partners to develop and commercialize cell and gene therapies and regenerative medicine technologies. Its services include business, technical and facilities. The company is headquartered in Toronto, Canada. | Biotechnology | Director/Board Member | |
Bedside Clinical Systems, Inc.
 Bedside Clinical Systems, Inc. Packaged SoftwareTechnology Services Bedside Clinical Systems, Inc. develops Responses to Illness Severity Quantification (RISQ) framework severity of illness clinical decision support for frontline healthcare professionals, hospital administrators and quality managers. It provides BedsidePEWS, that uses the RISQ framework to empower frontline clinicians who care for hospitalized children. The company was founded by Christopher Parshuram in March 2011 and is headquartered in Toronto, Canada. | Packaged Software | Director/Board Member | |
Clinical Trials Ontario
 Clinical Trials Ontario Miscellaneous Commercial ServicesCommercial Services Clinical Trials Ontario operates as a research and development company for various diseases. The company was founded in 2012 and is headquartered in Toronto, Canada. | Miscellaneous Commercial Services | Chairman | |
Accel-Rx
 Accel-Rx Financial ConglomeratesFinance Accel-Rx provides seed and start-up investment services to the new health sciences companies. It engages in leveraging investment support to the research and commercialization centers such as the existing health-related Centers of Excellence for Commercialization and Research (CECRs). The company was founded by Natalie Dakers in 2014 and is headquartered in Vancouver, Canada. | Financial Conglomerates | Director/Board Member | |
Encycle Therapeutics, Inc.
 Encycle Therapeutics, Inc. BiotechnologyHealth Technology Encycle Therapeutics, Inc. provides biotechnology services. It offers rapid synthesis of drug-like macrocycles or membrane-permeable nacellins which have enormous potential to target intracellular protein-protein interactions. The company was founded by Andrei Yudin is headquartered in Toronto, Canada. | Biotechnology | Chairman | |
| Process Industrial It & Automation | Director/Board Member | ||
| DOVA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member President | |
Triphase Accelerator Corp.
 Triphase Accelerator Corp. BiotechnologyHealth Technology Triphase Accelerator Corp. develops oncology drug therapeutics. It engages in accelerating oncology products from pre-investigational new drug (pre-IND) to Phase I/Phase II POC. The firm?s product includes Marizomib which is used in cancer treatment. The company is headquartered in Toronto, Canada. | Biotechnology | Chief Executive Officer | |
QD Solar, Inc.
 QD Solar, Inc. SemiconductorsElectronic Technology QD Solar, Inc. develops photovoltaic cells using colloidal quantum dot technology in Canada. Its quantum dot technology combines silicon solar cells with infrared solar cells in a hybrid architecture to harvest more of the solar spectrum than silicon alone. The company was founded by Sjoerd Hoogland and Edward Hartley Sargent in 2014 and is headquartered in Toronto, Canada. | Semiconductors | Director/Board Member | |
Fibrocor Therapeutics LP
 Fibrocor Therapeutics LP Miscellaneous Commercial ServicesCommercial Services Fibrocor Therapeutics LP is a privately held Canadian drug discovery company that is pioneering the use of tissue-specific therapeutics in the field of precision medicine, particularly in fibrosis. The company is based in Toronto, Canada. The company aims to improve the lives of patients by delivering transformative treatments that tackle the root causes of fibrosis, leading to better outcomes and enhanced quality of life. Fibrocor leverages its extensive expertise and one of the largest patient-derived clinically annotated biorepositories of fibrotic tissue to refine and validate therapeutic candidates, ensuring they meet the highest standards of efficacy and safety. | Miscellaneous Commercial Services | Chairman | |
| SCOPUS BIOPHARMA INC. | Pharmaceuticals: Other | Director/Board Member Director/Board Member | |
Notch Therapeutics, Inc.
 Notch Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Notch Therapeutics, Inc. engages in the development of cell therapies for the treatment of diseases. It offers technology platform, which uses genetically tailored stem cells as a renewable source for creating allogeneic T cell therapies that expand treatment options and deliver cell immunotherapies to patients. The company was founded by Juan Carlos Zuniga-Pflucker and Peter Zandstra in 2018 and is headquartered in Toronto, Canada. | Pharmaceuticals: Other | Chairman | |
| Arden Regulatory Clinical & Medical Consulting Ltd. | Director/Board Member | ||
| International Genetic Science Partnership | Corporate Officer/Principal | ||
| XERIS BIOPHARMA HOLDINGS, INC. | Biotechnology | Director/Board Member |
Statistik
International
| Israel | 17 |
| Vereinigte Staaten | 12 |
| Kanada | 12 |
| Schweden | 10 |
| Norwegen | 2 |
Sektoral
| Health Technology | 27 |
| Consumer Services | 10 |
| Commercial Services | 6 |
| Technology Services | 3 |
| Process Industries | 2 |
Operativ
| Director/Board Member | 128 |
| Corporate Officer/Principal | 37 |
| Independent Dir/Board Member | 37 |
| Chairman | 29 |
| Undergraduate Degree | 19 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Raf Hofstein | 36 |
| Michael Anghel | 32 |
| Aharon Schwartz | 29 |
| Sandra Panem | 18 |
| Barbara-Jean Bormann-Kennedy | 16 |
| Henrik Stenqvist | 16 |
| An van Es-Johansson | 13 |
| Avraham Molcho | 13 |
| Rami Dar | 11 |
| Philip Serlin | 10 |
| Paula Treutiger | 9 |
| Kirsti Gjellan | 9 |
| Amy Pott | 7 |
| Pablo de Mora | 7 |
| Tali Yaron Dalah | 6 |
